Kuliah Rematologi 3
-
Upload
asri-prameswari -
Category
Documents
-
view
213 -
download
0
description
Transcript of Kuliah Rematologi 3
![Page 1: Kuliah Rematologi 3](https://reader035.fdocuments.us/reader035/viewer/2022080905/563db931550346aa9a9af2cc/html5/thumbnails/1.jpg)
1
High Impact Rheumatology
Evaluation and Management of Osteoarthritis
Osteoarthritis: Case 1§ A 65-year-old man comes to your office
complaining of knee pain that began insidiously about a year ago. He has no other rheumatic symptoms§ What further questions should you ask?§ What are the pertinent physical findings?§ Which diagnostic studies are appropriate?
OA: Symptoms and Signs§ Pain is related to use§ Pain gets worse
during the day§ Minimal morning
stiffness (<20 min) and after inactivity (gelling)§ Range of motion
decreases
§ Joint instability § Bony enlargement§ Restricted movement§ Crepitus§ Variable swelling
and/or instability
![Page 2: Kuliah Rematologi 3](https://reader035.fdocuments.us/reader035/viewer/2022080905/563db931550346aa9a9af2cc/html5/thumbnails/2.jpg)
2
OA Case 1: Radiographic Features§ Joint space narrowing§ Marginal osteophytes§ Subchondral cysts§ Bony sclerosis§ Malalignment§ NAILS THE
DIAGNOSIS
OA: Laboratory Tests§ No specific tests§ No associated laboratory abnormalities;
eg, sedimentation rate§ Investigational: Cartilage degradation products in
serum and joint fluid
OA: Risk Factors§ Why did this patient develop osteoarthritis?
![Page 3: Kuliah Rematologi 3](https://reader035.fdocuments.us/reader035/viewer/2022080905/563db931550346aa9a9af2cc/html5/thumbnails/3.jpg)
3
OA: Risk Factors (cont’d)§ Age: 75% of persons over age 70 have OA§ Female sex§ Obesity§ Hereditary§ Trauma§ Neuromuscular dysfunction§ Metabolic disorders
Case 1: Cause of Knee OA§ On further questioning, patient recalls fairly
serious knee injury during sport event many years ago§ Therefore, posttraumatic OA is most likely
diagnosis
are needed to use this picture
Case 1: Prognosis § Natural history of OA: Progressive cartilage loss,
subchondral thickening, marginal osteophytes
![Page 4: Kuliah Rematologi 3](https://reader035.fdocuments.us/reader035/viewer/2022080905/563db931550346aa9a9af2cc/html5/thumbnails/4.jpg)
4
OA: Case 2§ A 75-year-old woman presents to your office with
complaints of pain and stiffness in both knees, hips, and thumbs. She also has occasional back pain§ Family history reveals that her mother had similar
problems§ On exam she has bony enlargement of both
knees, restricted ROM of both hips, squaring at base of both thumbs, and multiple Heberden’sand Bouchard’s nodes
Distribution of Primary OA§ Primary OA typically
involves variable number of joints in characteristic locations, as shown§ Exceptions may occur,
but should trigger consideration of secondary causes of OA
0
20
40
60
80
20 40 60 80
Men
Age (years)
Pre
vale
nce
of O
A (
%)
0
20
40
60
80
20 40 60 80
Women
Age (years)
Pre
vale
nce
of O
A (
%)
Age-Related Prevalence of OA: Changes on X-Ray
DIP
Knee
Hip
DIP
Knee
Hip
![Page 5: Kuliah Rematologi 3](https://reader035.fdocuments.us/reader035/viewer/2022080905/563db931550346aa9a9af2cc/html5/thumbnails/5.jpg)
5
Case 2: Distal and Proximal Interphalangeal Joints
§ Radiograph shows severe changes§ Most common
location in hand§ May cause significant
loss of function
Case 2: Carpometacarpal Joint
§ X-ray shows osteophytes, subchondral sclerosis, and complete loss of joint space§ Patients often present
with deep groin pain that radiates into the medial thigh
Case 2: Hip Joint
![Page 6: Kuliah Rematologi 3](https://reader035.fdocuments.us/reader035/viewer/2022080905/563db931550346aa9a9af2cc/html5/thumbnails/6.jpg)
6
What If Case 2 Had OA in the “Wrong” Joint, eg, the Ankle?
• Then you must consider secondary causes of OA• Ask about previous trauma and/or overuse• Consider neuromuscular disease, especially
diabetic or other neuropathies• Consider metabolic disorders, especially
CPPD (calcium pyrophosphate deposition disease—aka pseudogout)
Secondary OA: Diabetic Neuropathy§ MTPs 2 to 5 involved
in addition to the 1st bilaterally§ Destructive changes
on x-ray far in excess of those seen in primary OA§ Midfoot involvement
also common
Underlying Disease Associations of OA and CPPD Disease (pseudogout)§ Hemochromatosis§ Hyperparathyroidism§ Hypothyroidism§ Hypophosphatasia§ Hypomagnesemia§ Neuropathic joints§ Trauma§ Aging, hereditary
![Page 7: Kuliah Rematologi 3](https://reader035.fdocuments.us/reader035/viewer/2022080905/563db931550346aa9a9af2cc/html5/thumbnails/7.jpg)
7
Management of OA• Establish the diagnosis of OA on the basis of
history and physical and x-ray examinations• Decrease pain to increase function• Prescribe progressive exercise to
• Increase function• Increase endurance and strength• Reduce fall risk
• Patient education: Self-Help Course• Weight loss• Heat/cold modalities
Pharmacologic Management of OA§ Nonopioid analgesics§ Topical agents§ Intra-articular agents§ Opioid analgesics§ NSAIDs§ Unconventional therapies
Strengthening Exercise for OA• Decreases pain and increases function• Physical training rather than passive therapy• General program for muscle strengthening
• Warm-up with ROM stretching• Step 1: Lift the body part against gravity, begin
with 6 to 10 repetitions• Step 2: Progressively increase resistance with
free weights or elastic bands• Cool-down with ROM stretching
Rogind, et al. Arch Phys Med Rehabil . 1998;79:1421–1427.Jette, et al. Am J Public Health. 1999;89:66–72.
![Page 8: Kuliah Rematologi 3](https://reader035.fdocuments.us/reader035/viewer/2022080905/563db931550346aa9a9af2cc/html5/thumbnails/8.jpg)
8
Reconditioning Exercise Program for OA
• Low -impact, continuous movement exercise for 15 to 30 minutes 3 times per week• Fitness walking: Increases endurance, gait
speed, balance, and safety• Aquatics exercise programs —group support• Exercycle with minimal or no tension• Treadmill with minimal or no elevation
Nonopioid Analgesic Therapy• First-line—Acetaminophen
• Pain relief comparable to NSAIDs, less toxicity• Beware of toxicity from use of multiple
acetaminophen-containing products• Maximum safe dose = 4 grams/day
Nonopioid Analgesic Therapy (cont’d)• NSAIDs
• Use generic NSAIDs first• If no response to one may respond to another• Lower doses may be effective• Do not retard disease progression• Gastroprotection increases expense• Side effects: GI, renal, worsening CHF, edema• Antiplatelet effects may be hazardous
![Page 9: Kuliah Rematologi 3](https://reader035.fdocuments.us/reader035/viewer/2022080905/563db931550346aa9a9af2cc/html5/thumbnails/9.jpg)
9
* P<.05
Bradley, et al. N Engl J Med. 1991;325:87–91.
Ibuprofen vs Acetaminophen for Knee OA—Equivalent Benefit
0 0.2 0.4 0.6 0.8
HAQ Pain
Walking Pain
Rest Pain*
50 Ft Walk
HAQ Disability
Change in Score
2400 Ibuprofen1200 IbuprofenAcetaminophen
Nonopioid Analgesics in OA• Cyclooxygenase-2 (COX-2) inhibitors
• Pain relief equivalent to older NSAIDs• Probably less GI toxicity• No effect on platelet aggregation or bleeding
time• Side effects: Renal, edema• Older populations with multiple medical
problems not tested• Cost similar to generic NSAIDs plus proton
pump inhibitor or misoprostol
Medical Letter. 1999;41:11–12.
Medical Letter. 1999;41:11–12.
Nonopioid Analgesics in OA (cont’d)• Tramadol
• Affects opioid and serotonin pathways• Nonulcerogenic• May be added to NSAIDs, acetaminophen• Side effects: Nausea, vomiting, lowered
seizure threshold, rash, constipation, drowsiness, dizziness
![Page 10: Kuliah Rematologi 3](https://reader035.fdocuments.us/reader035/viewer/2022080905/563db931550346aa9a9af2cc/html5/thumbnails/10.jpg)
10
Opioid Analgesics for OA• Codeine, oxycodone
• Anticipate and prevent constipation• Long-acting oxycodone may have fewer CNS
side effects• Propoxyphene• Morphine and fentanyl patches for severe pain
interfering with daily activity and sleep
Topical Agents for Analgesia in OA• Local cold or heat: Hot packs, hydrotherapy• Capsaicin-containing topicals
• Use well supported by evidence • Use daily for up to 2 weeks before benefit• Compliance poor without full instruction• Avoid contact with eyes
• Liniments = methyl salicylates• Temporary benefit
OA: Intra-articular Therapy• Intra-articular steroids
• Good pain relief • Most often used in
knees, up to q 3 mo• With frequent
injections, risk infection, worsening diabetes, or CHF
• Joint lavage
• Significant symptomatic benefit demonstrated
• Hyaluronate injections*
• Symptomatic relief • Improved function
• Expensive• Require series of
injections• No evidence of long-
term benefit
• Limited to knees
* Altman, et al. J Rheumatol. 1998;25:2203.
![Page 11: Kuliah Rematologi 3](https://reader035.fdocuments.us/reader035/viewer/2022080905/563db931550346aa9a9af2cc/html5/thumbnails/11.jpg)
11
OA: Unconventional Therapies• Polysulfated glycosaminoglycans—nutriceuticals
• Glucosamine +/- chondroitin sulfate: Symptomatic benefit, no known side effects, long-term controlled trials pending
• Tetracyclines as protease/cytokine inhibitors• Under study• Have disease-modifying potential
OA: Unconventional Therapies (cont’d)• Keep in touch with current information. The
unconventional may become conventional• www.quackwatch.com• ACR Website
(http://www.rheumatology.org)• Arthritis Foundation Website
(www.arthritis.org)
Surgical Therapy for OA• Arthroscopy
• May reveal unsuspected focal abnormalities• Results in tidal lavage• Expensive, complications possible
• Osteotomy : May delay need for TKR for 2 to 3 years
• Total joint replacement: When pain severe and function significantly limited
![Page 12: Kuliah Rematologi 3](https://reader035.fdocuments.us/reader035/viewer/2022080905/563db931550346aa9a9af2cc/html5/thumbnails/12.jpg)
12
OA: Management Summary• First: Be sure the pain is joint related (not a
tendonitis or bursitis adjacent to joint)• Initial treatment
• Muscle strengthening exercises and reconditioning walking program
• Weight loss• Acetaminophen first• Local heat/cold and topical agents
OA: Management Summary (cont’d)• Second-line approach
• NSAIDs if acetaminophen fails• Intra-articular agents or lavage• Opioids
• Third-line • Arthroscopy• Osteotomy• Total joint replacement